profit ratio toward sales revenue was decreased 48.01 % from previous year to 44.82%. It came from the sales of high cost goods with the higher portion and the sales promotion activities to clear existing
which have not yet recovered. The high liability affected the expense atmosphere to be sluggish. Cost of goods sold was 641.29 million baht or equivalent to 50.31% gaining from sales revenue which it
, higher repair and maintenance expenditure of medical equipment, and higher depreciation and amortization expenses resulted from the expansions of a new hospital and new specialized centers in the existing
many areas and debt amount remained in high level. Confident index of consumer continuously decreased. Therefore, it affected the expense atmosphere to be sluggish. Cost of goods sold was 138.13 million
from utility expense and cost related to sales such as marketing expense. Furthermore, SG&A as a percentage of sales has marginally improved, resulting to the decrease from 22.87% in the second quarter
organization levels were controlled following the cost reduction initiative to combat COVID-19 situation. In addition, put off 2020 capital expenditure plan to prepare sufficient liquidity amidst uncertainty
was increased from previous year 52.55% to 54.21%. It came from the sales of high cost goods with the increased portion and the sales promotion activities to clear existing goods in stock. Distribution
(Cambodia) 0% 0% 0% IC (Thailand) 33% 33% 34% IC (China) 4% 5% 6% HTI (USA) 4% 5% 5% 100% 100% 100% Gross Profit / Cost of Sales Analysis and Sales and Administration Analysis Gross Profit decreased by THB
strictly cost control. In addition, some expenses were recorded as finance costs due to the adoption of TFRS No.9 Financial Instrument and TFRS No. 16 Leases since 2020. 6. Administrative expense was THB